These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21543345)

  • 1. Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors.
    Kamimae S; Yamamoto E; Yamano HO; Nojima M; Suzuki H; Ashida M; Hatahira T; Sato A; Kimura T; Yoshikawa K; Harada T; Hayashi S; Takamaru H; Maruyama R; Kai M; Nishiwaki M; Sugai T; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
    Cancer Prev Res (Phila); 2011 May; 4(5):674-83. PubMed ID: 21543345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Developing technologies for epigenomic analysis and clinical application of molecular diagnosis].
    Yamamoto E; Suzuki H; Maruyama R; Shinomura Y
    Rinsho Byori; 2012 Jul; 60(7):637-43. PubMed ID: 22973723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer.
    Harada T; Yamamoto E; Yamano HO; Nojima M; Maruyama R; Kumegawa K; Ashida M; Yoshikawa K; Kimura T; Harada E; Takagi R; Tanaka Y; Aoki H; Nishizono M; Nakaoka M; Tsuyada A; Niinuma T; Kai M; Shimoda K; Shinomura Y; Sugai T; Imai K; Suzuki H
    Cancer Prev Res (Phila); 2014 Oct; 7(10):1002-10. PubMed ID: 25139296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors.
    Hashimoto K; Shimizu Y; Suehiro Y; Okayama N; Hashimoto S; Okada T; Hiura M; Ueno K; Hazama S; Higaki S; Hamanaka Y; Oka M; Sakaida I; Hinoda Y
    Mol Carcinog; 2008 Jan; 47(1):1-8. PubMed ID: 17620311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers.
    Nosho K; Yamamoto H; Takahashi T; Mikami M; Taniguchi H; Miyamoto N; Adachi Y; Arimura Y; Itoh F; Imai K; Shinomura Y
    Carcinogenesis; 2007 Jun; 28(6):1364-70. PubMed ID: 17183069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.
    Hiraoka S; Kato J; Tatsukawa M; Harada K; Fujita H; Morikawa T; Shiraha H; Shiratori Y
    Gastroenterology; 2006 Aug; 131(2):379-89. PubMed ID: 16890591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
    Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD
    J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.
    Model F; Osborn N; Ahlquist D; Gruetzmann R; Molnar B; Sipos F; Galamb O; Pilarsky C; Saeger HD; Tulassay Z; Hale K; Mooney S; Lograsso J; Adorjan P; Lesche R; Dessauer A; Kleiber J; Porstmann B; Sledziewski A; Lofton-Day C
    Mol Cancer Res; 2007 Feb; 5(2):153-63. PubMed ID: 17314273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved fecal DNA test for colorectal cancer screening.
    Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability.
    Ward RL; Cheong K; Ku SL; Meagher A; O'Connor T; Hawkins NJ
    J Clin Oncol; 2003 Oct; 21(20):3729-36. PubMed ID: 14551292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
    Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
    Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer.
    Wiencke JK; Zheng S; Lafuente A; Lafuente MJ; Grudzen C; Wrensch MR; Miike R; Ballesta A; Trias M
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):501-6. PubMed ID: 10385139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors.
    Sakamoto N; Terai T; Ajioka Y; Abe S; Kobayasi O; Hirai S; Hino O; Watanabe H; Sato N; Shimoda T; Fujii H
    Oncogene; 2004 Nov; 23(55):8900-7. PubMed ID: 15480433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
    Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.